2-hydroxymethyl benzoic acid (CAS No 612-20-4) is an important compound in biomedical research particularly within the fields of pharmacology and medicinal chemistry Originating from the salicylic acid family this compound targets specific biochemical pathways including those involved in inflammation and pain modulation It exhibits common in vitro activity within the nanomolar to low micromolar range making it effective for study in various experimental models In cell models it is utilized to assess anti-inflammatory properties and pain-relief potential often serving as a reference substance in drug screening assays In animal studies it aids in the exploration of therapeutic effects and toxicity profiles contributing valuable insights for preclinical evaluations Experimental concentrations typically depend on the specific research design allowing for flexibility in its application across diverse experimental settings